共有 50 笔近期内部人交易记录记录，涉及 GlycoMimetics, Inc. (GLYC), 包括 36 笔买入 和 14 笔卖出. 内部人买入总额为 $6.73M 内部人卖出总额为 $1.54M.
近期活跃的重要内部人包括 Invus Public Equities, L.p., Siren, L.l.c., Rock Edwin. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — GLYC
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-08-08 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
260,873 |
$0.19 |
$50.01K |
6,317,565 |
| 2024-08-07 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
61,488 |
$0.18 |
$11.2K |
6,578,438 |
| 2024-08-06 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
55,732 |
$0.18 |
$10.19K |
6,639,926 |
| 2024-08-05 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
164,523 |
$0.19 |
$31K |
6,695,658 |
| 2024-08-02 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
286,200 |
$0.20 |
$57.35K |
6,860,181 |
| 2024-08-01 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
63,564 |
$0.22 |
$13.74K |
7,146,381 |
| 2024-07-30 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
756,835 |
$0.22 |
$167.18K |
7,209,945 |
| 2024-07-29 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
363,949 |
$0.24 |
$85.64K |
7,966,780 |
| 2024-07-26 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情卖出 |
258,335 |
$0.24 |
$62.44K |
8,330,729 |
| 2024-07-25 |
Siren, L.l.c. |
10 Percent Owner |
处置 |
- |
- |
- |
8,589,064 |
| 2024-06-21 |
Rock Edwin |
Chief Medical Officer |
知情买入 |
115,000 |
$0.27 |
$30.72K |
680,403 |
| 2024-06-20 |
Rock Edwin |
Chief Medical Officer |
知情买入 |
190,000 |
$0.25 |
$48.11K |
565,403 |
| 2024-06-18 |
Hahn Brian M. |
SVP Finance, CFO |
知情买入 |
17,500 |
$0.25 |
$4.33K |
70,643 |
| 2024-05-01 |
Junius Daniel M |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Andrews Patricia S |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Pearson Timothy R |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Goldberg Mark Alan |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Jackson Scott Thomas |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Koenig Scott |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
King Rachel K. |
Director |
限制性股票授予 (RSU) |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-03-29 |
Junius Daniel M |
Director |
限制性股票授予 (RSU) |
5,209 |
$3.00 |
$15.63K |
98,459 |
| 2024-03-29 |
Goldberg Mark Alan |
Director |
限制性股票授予 (RSU) |
4,584 |
$3.00 |
$13.75K |
24,828 |
| 2024-03-29 |
King Rachel K. |
Director |
限制性股票授予 (RSU) |
3,334 |
$3.00 |
$10K |
515,194 |
| 2024-01-12 |
Hahn Brian M. |
SVP Finance, CFO |
限制性股票授予 (RSU) |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Semerjian Harout |
Chief Executive Officer |
限制性股票授予 (RSU) |
695,000 |
$3.11 |
$2.16M |
695,000 |
| 2024-01-12 |
Rock Edwin |
Chief Medical Officer |
限制性股票授予 (RSU) |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Rath Chinmaya |
SVP and Chief Business Officer |
限制性股票授予 (RSU) |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
限制性股票授予 (RSU) |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2023-12-29 |
Andrews Patricia S |
Director |
限制性股票授予 (RSU) |
5,191 |
$2.36 |
$12.25K |
58,608 |
| 2023-12-29 |
Goldberg Mark Alan |
Director |
限制性股票授予 (RSU) |
5,827 |
$2.36 |
$13.75K |
20,244 |
| 2023-12-29 |
King Rachel K. |
Director |
限制性股票授予 (RSU) |
4,238 |
$2.36 |
$10K |
511,860 |
| 2023-09-30 |
Andrews Patricia S |
Director |
限制性股票授予 (RSU) |
8,167 |
$1.50 |
$12.25K |
53,417 |
| 2023-09-30 |
Goldberg Mark Alan |
Director |
限制性股票授予 (RSU) |
9,167 |
$1.50 |
$13.75K |
14,417 |
| 2023-09-30 |
King Rachel K. |
Director |
限制性股票授予 (RSU) |
6,667 |
$1.50 |
$10K |
507,622 |
| 2023-09-22 |
Rock Edwin |
Chief Medical Officer |
知情买入 |
30,403 |
$1.38 |
$41.96K |
375,403 |
| 2023-09-21 |
Rock Edwin |
Chief Medical Officer |
知情买入 |
35,000 |
$1.38 |
$48.3K |
345,000 |
| 2023-06-01 |
Koenig Scott |
Director |
期权行权（卖出） |
21,000 |
$0.60 |
$12.6K |
- |
| 2023-05-19 |
Junius Daniel M |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Andrews Patricia S |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Pearson Timothy R |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Goldberg Mark Alan |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Jackson Scott Thomas |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Koenig Scott |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
King Rachel K. |
Director |
限制性股票授予 (RSU) |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-17 |
Hahn Brian M. |
SVP Finance, CFO |
知情卖出 |
3,700 |
$1.95 |
$7.22K |
53,143 |
| 2023-05-10 |
Junius Daniel M |
Director |
知情买入 |
30,000 |
$1.56 |
$46.8K |
93,250 |
| 2023-05-08 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
知情买入 |
13,500 |
$1.57 |
$21.2K |
138,980 |
| 2023-03-23 |
Rath Chinmaya |
SVP and Chief Business Officer |
处置 |
150,000 |
$3.48 |
$522K |
- |
| 2023-03-23 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
处置 |
200,000 |
$2.55 |
$510K |
- |
| 2023-02-24 |
Invus Public Equities, L.p. |
10 Percent Owner |
知情买入 |
100,000 |
$1.70 |
$170K |
8,589,064 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
